FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus

Overview of attention for article published in Frontiers in immunology, May 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 69,426 followers.

I think this may be discussed further in this paper: https://t.co/JpEK85cFfu (cc: @C_Scheibenbogen)

RT @Leo09416981: @BertrandBio @BowTiedBiotech Yeah, will need longer term follow up to conclude these are real CRs. Many pts on prednisone…

RT @Leo09416981: @BertrandBio @BowTiedBiotech Yeah, will need longer term follow up to conclude these are real CRs. Many pts on prednisone…

@BertrandBio @BowTiedBiotech Yeah, will need longer term follow up to conclude these are real CRs. Many pts on prednisone concurrently. C4 at 25mpk is not a real world drug. https://t.co/XP2zJ13m49 https://t.co/RPr4yaYzqB

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.